192 related articles for article (PubMed ID: 37150266)
21. Effects of long-chain omega-3 polyunsaturated fatty acids on reducing anxiety and/or depression in adults; A systematic review and meta-analysis of randomised controlled trials.
Kelaiditis CF; Gibson EL; Dyall SC
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102572. PubMed ID: 37028202
[TBL] [Abstract][Full Text] [Related]
22. Dietary fatty acids and risk for Alzheimer's disease, dementia, and mild cognitive impairment: A prospective cohort meta-analysis.
Zhu RZ; Chen MQ; Zhang ZW; Wu TY; Zhao WH
Nutrition; 2021 Oct; 90():111355. PubMed ID: 34218119
[TBL] [Abstract][Full Text] [Related]
23. Fish intake, n-3 fatty acid body status, and risk of cognitive decline: a systematic review and a dose-response meta-analysis of observational and experimental studies.
Kosti RI; Kasdagli MI; Kyrozis A; Orsini N; Lagiou P; Taiganidou F; Naska A
Nutr Rev; 2022 May; 80(6):1445-1458. PubMed ID: 34605891
[TBL] [Abstract][Full Text] [Related]
24. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD003177. PubMed ID: 30521670
[TBL] [Abstract][Full Text] [Related]
25. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; AlAbdulghafoor FK; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2018 Jul; 7(7):CD003177. PubMed ID: 30019766
[TBL] [Abstract][Full Text] [Related]
26. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
[TBL] [Abstract][Full Text] [Related]
27. Higher Serum DHA and Slower Cognitive Decline in Patients with Alzheimer's Disease: Two-Year Follow-Up.
Chu CS; Hung CF; Ponnusamy VK; Chen KC; Chen NC
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334816
[TBL] [Abstract][Full Text] [Related]
28. The Potential Cardiometabolic Effects of Long-Chain ω-3 Polyunsaturated Fatty Acids: Recent Updates and Controversies.
Bae JH; Lim H; Lim S
Adv Nutr; 2023 Jul; 14(4):612-628. PubMed ID: 37031750
[TBL] [Abstract][Full Text] [Related]
29. Omega 3 fatty acid for the prevention of cognitive decline and dementia.
Sydenham E; Dangour AD; Lim WS
Cochrane Database Syst Rev; 2012 Jun; (6):CD005379. PubMed ID: 22696350
[TBL] [Abstract][Full Text] [Related]
30. Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.
Sbidian E; Chaimani A; Garcia-Doval I; Do G; Hua C; Mazaud C; Droitcourt C; Hughes C; Ingram JR; Naldi L; Chosidow O; Le Cleach L
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011535. PubMed ID: 29271481
[TBL] [Abstract][Full Text] [Related]
31. High-dose omega-3 polyunsaturated fatty acid supplementation might be more superior than low-dose for major depressive disorder in early therapy period: a network meta-analysis.
Luo XD; Feng JS; Yang Z; Huang QT; Lin JD; Yang B; Su KP; Pan JY
BMC Psychiatry; 2020 May; 20(1):248. PubMed ID: 32434488
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review.
Canhada S; Castro K; Perry IS; Luft VC
Nutr Neurosci; 2018 Oct; 21(8):529-538. PubMed ID: 28466678
[TBL] [Abstract][Full Text] [Related]
33. Associations and effects of omega-3 polyunsaturated fatty acids on cognitive function and mood in healthy adults: a protocol for a systematic review of observational and interventional studies.
O' Donovan F; Carney S; Kennedy J; Hayes H; Pender N; Boland F; Stanton A
BMJ Open; 2019 Jun; 9(6):e027167. PubMed ID: 31230010
[TBL] [Abstract][Full Text] [Related]
34. A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
Lin PY; Su KP
J Clin Psychiatry; 2007 Jul; 68(7):1056-61. PubMed ID: 17685742
[TBL] [Abstract][Full Text] [Related]
35. New perspectives on randomized controlled trials with omega-3 fatty acid supplements and cognition: A scoping review.
Andriambelo B; Stiffel M; Roke K; Plourde M
Ageing Res Rev; 2023 Mar; 85():101835. PubMed ID: 36603691
[TBL] [Abstract][Full Text] [Related]
36. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
[TBL] [Abstract][Full Text] [Related]
37. Are omega-3 fatty acids options for prevention and treatment of cognitive decline and dementia?
Cederholm T; Palmblad J
Curr Opin Clin Nutr Metab Care; 2010 Mar; 13(2):150-5. PubMed ID: 20019606
[TBL] [Abstract][Full Text] [Related]
38. Omega-3 fatty acids and cognitive function.
Welty FK
Curr Opin Lipidol; 2023 Feb; 34(1):12-21. PubMed ID: 36637075
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
